期刊
PHARMACOGENOMICS
卷 23, 期 8, 页码 453-456出版社
FUTURE MEDICINE LTD
DOI: 10.2217/pgs-2022-0054
关键词
cytochrome P450; depression; polymorphism; schizophrenia; twin studies
资金
- European Research Council [742020]
- Swedish Research Council [2021-02732]
- EU [668353/U-PGx]
- Swedish Research Council [2021-02732] Funding Source: Swedish Research Council
- European Research Council (ERC) [742020] Funding Source: European Research Council (ERC)
Genetic variation in polymorphic genes plays a crucial role in influencing the pharmacokinetics and pharmacodynamics of different drugs through various mechanisms, contributing to the observed phenotypic variability.
it is most likely that genetic variation in a multitude of different polymorphic genes is responsible, where the gene products in one way or another influence the pharmacokinetics and pharmacodynamics of different drugs by many different mechanisms and thereby contribute to the phenotypic variability observed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据